ALVO vs PINC: fair value comparison
Alvotech and Premier, Inc. · Updated 2026-10-19
ALVO's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. PINC has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, PINC currently ranks higher by quality score.
| ALVO | PINC | |
|---|---|---|
| Verdict | Awaiting full valuation | No estimate yet |
| Last price | $5.00 | $49.24 |
| 12-month range | $3.00–$8.40 | $49.05–$49.80 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #117 of 301 Healthcare | #115 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | Low | Low |
| Margin trend | Expanding | Expanding |
| Revenue growth | High | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| 52-week position | The lower-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: ALVO fair value analysis · PINC fair value analysis